1. All-trans retinoic acid induces p53-depenent apoptosis in human hepatocytes by activating p14 expression via promoter hypomethylation
   Shin-Hee Heo et al, 2015, Cancer Letters CrossRef
2. Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies
   Kelly J. Norsworthy et al, 2016, Leukemia Research CrossRef
3. Low-dose decitabine plus all-trans retinoic acid in patients with myeloid neoplasms ineligible for intensive chemotherapy
   Wei Wu et al, 2016, Annals of Hematology CrossRef
4. All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex
   Lu Wang et al, 2023, British Journal of Cancer CrossRef
5. Exploring the nexus of nuclear receptors in hematological malignancies
   Mukesh Kumar Manickasamy et al, 2024, Cellular and Molecular Life Sciences CrossRef
6. DNA Methyltransferase Inhibitors: Development and Applications
   Marie Lopez et al, 2016, DNA Methyltransferases - Role and Function CrossRef
7. Changes in expression of WT1 during induced differentiation of the acute myeloid leukemia cell lines by treatment with 5-aza-2′-deoxycytidine and all-trans retinoic acid
   LILI XIANG et al, 2016, Oncology Letters CrossRef
8. Potential role for all-trans retinoic acid in nonpromyelocytic acute myeloid leukemia
   Hayley S Ma et al, 2016, International Journal of Hematologic Oncology CrossRef
9. DNA Methylation: Biological Implications and Modulation of Its Aberrant Dysregulation
   Alessia Lucidi et al, 2019, The DNA, RNA, and Histone Methylomes CrossRef
10. Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia
    Yan Lin et al, 2019, Journal of International Medical Research CrossRef